FdaApplication

ANDA 218691

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFDC LTD
application_typeANDA
approval_date2026-05-14

Products (2)

ProductActive ingredientStrengthDosage form
CEFIXIMECEFIXIME100MG/5MLFOR SUSPENSION;ORAL
CEFIXIMECEFIXIME200MG/5MLFOR SUSPENSION;ORAL

2 products